Article Figures & Data
Tables
- Table 1
- Comparison of demographic characteristics of people living with human immunodeficiency virus and healthy controls
Parameters Patient (n=99) Control (n=80) P-value Age (Years) 39±10.2 35.8±14.5 0.071 >50 years, n(%) 12 (12.1) 16 (20.0) 0.217 Married, n(%) 33 (48.5) 30 (37.5) 0.244 Male gender, n(%) 87 (87.9) 65 (81.3) 0.307 Body mass index (kg/m2) 25.7±4.6 25.6±4.3 0.913 Neck circumference (cm) 39.4±2.4 39.9±3.9 0.548 - Table 2
- Findings of sleep quality obtained by using Stanford Sleepiness Scale in people living with human immunodeficiency virus and healthy controls.
Sleepness state Patient n (%) Control n (%) P-value Feeling active and constantly awake 27 (27.3) 17 (21.3) 0.450 Functions at a high level but not maximum, able to concentrate on work 22 (22.3) 45 (67) <0.001 Awake but relaxed, responsive but not fully alert 7 (7.1) 11 (13.8) 0.220 Sometimes absent-minded 19 (19.2) 3 (3.8) 0.004 Absent-minded and slowed movements 10 (10.1) 2 (2.5) 0.085 Significant drowsiness, prefers to lie down all the time 18 (18.2) 2 (2.5) 0.002 Cannot stay awake 1 (1.0) 0 (0) NA N/A: not applicable
- Table 3
- Comparison of sleep components between patient and control groups according to Pitsburg Sleep Quality Scale.
Components Patient (score ± SD) Control (score ±SD) P-value 1 Subjective sleep quality 1.18±0.87 1.04±0.79 0.324 2 Sleep latency 1.33 ± 1.02 1.13 ±0.85 0.205 3 Sleep time 1.04±0.99 0.93±1.09 0.286 4 Sleep activity 0.57±0.93 0.35± 0.80 0.054 5 Sleep disorder 1.15±0.61 1.08±0.50 0.312 6 Drug use 0.07±0.36 0.11 ± 0.45 0.492 7 Daily functions 0.98±0.95 0.60 ± 0.84 0.004 Total score 6.32±3.62 5.23 ± 3.25 0.031 Poor sleep quality (score >5) 57 (57.6%) 38 (47.5%) 0.179 - Table 4
- Obstructive sleep apnea risk evaluation of patient and control groups by Berlin Survey.
Category Patient (n=99) Control (n=80) 1 (≥2 questions) 26 (26.2%) 22 (27.5%) 2 (≥2 questions) 32 (32.3%) 17 (21.2%) 3 (≥2 questions) 12 (12,1%) 15 (18.8%) Total: (≥2 categories) 19 (19.2%) 11 (13.8%)